ANI Pharmaceuticals, Inc.
ANIP
$82.10
-$0.57-0.69%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 21.45% | 44.03% | 2.66% | -1.38% | -37.96% |
| Total Receivables | 11.95% | 2.41% | -0.63% | 12.92% | 18.22% |
| Inventory | 5.90% | 0.66% | 0.46% | -7.61% | 18.01% |
| Prepaid Expenses | 23.91% | -35.96% | 30.10% | 2.89% | 26.09% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2,724.40% | 43.59% | 0.43% | -96.32% | 100.16% |
| Total Current Assets | 15.89% | 12.37% | 1.63% | 1.23% | -6.15% |
|
|
|||||
| Total Current Assets | 15.89% | 12.37% | 1.63% | 1.23% | -6.15% |
| Net Property, Plant & Equipment | 7.28% | 1.84% | 2.31% | 0.28% | 9.81% |
| Long-term Investments | 3.22% | -0.21% | 1.12% | -0.72% | 114.12% |
| Goodwill | 3.22% | -0.21% | 1.12% | -0.72% | 114.12% |
| Total Other Intangibles | -3.94% | -3.38% | -0.62% | -4.91% | 211.25% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -18.56% | 1.49% | 6.90% | 22.38% | -20.46% |
| Total Assets | 4.85% | 3.91% | 0.68% | -0.29% | 39.82% |
|
|
|||||
| Total Accounts Payable | 27.90% | 2.85% | 16.21% | -25.02% | 25.08% |
| Total Accrued Expenses | 16.18% | 44.50% | -11.10% | 8.64% | 49.96% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.32% | 18.07% | -0.16% | 56.75% | 741.41% |
| Total Finance Division Other Current Liabilities | -4.56% | -7.77% | 23.51% | 20.08% | 10.40% |
| Total Other Current Liabilities | -4.56% | -7.77% | 23.51% | 20.08% | 10.40% |
| Total Current Liabilities | 14.24% | 17.35% | 4.20% | 1.97% | 35.69% |
|
|
|||||
| Total Current Liabilities | 14.24% | 17.35% | 4.20% | 1.97% | 35.69% |
| Long-Term Debt | -0.54% | -0.54% | -0.54% | -0.53% | 117.38% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 68.31% | -4.62% | 54.32% | -34.49% | 48.41% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -47.69% | 3.59% | -32.19% | 1.27% | 274.06% |
| Total Liabilities | 2.38% | 3.82% | -0.73% | -0.16% | 94.61% |
|
|
|||||
| Common Stock & APIC | 8.18% | 2.04% | 2.19% | 1.71% | -4.06% |
| Retained Earnings | 34.18% | 9.58% | 15.23% | -11.92% | -37.79% |
| Treasury Stock & Other | -5.46% | -3.09% | -74.78% | -2.21% | -31.09% |
| Total Common Equity | 15.81% | 4.33% | 3.70% | -0.56% | -10.93% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 15.81% | 4.33% | 3.70% | -0.56% | -10.93% |
| Total Preferred Equity | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 9.58% | 4.09% | 3.49% | -0.53% | -10.36% |
|
|
|||||